A Scalable, Easy-to-Deploy Protocol for Cas13-Based Detection of SARS-CoV-2 Genetic Material
Open Access
- 19 March 2021
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 59 (4)
Abstract
The COVID-19 pandemic has created massive demand for widespread, distributed tools for detecting SARS-CoV-2 genetic material. The hurdles to scalable testing include reagent and instrument accessibility, availability of highly trained personnel, and large upfront investment.Keywords
All Related Versions
This publication has 28 references indexed in Scilit:
- Sensitivity of Chest CT for COVID-19: Comparison to RT-PCRRadiology, 2020
- Chest CT for Typical Coronavirus Disease 2019 (COVID-19) Pneumonia: Relationship to Negative RT-PCR TestingRadiology, 2020
- Validation of use of the miniPCR thermocycler for Ebola and Zika virus detectionPLOS ONE, 2019
- Functionally diverse type V CRISPR-Cas systemsScience, 2019
- CRISPR-typing PCR (ctPCR), a new Cas9-based DNA detection methodScientific Reports, 2018
- Field-deployable viral diagnostics using CRISPR-Cas13Science, 2018
- Real-time DNA barcoding in a rainforest using nanopore sequencing: opportunities for rapid biodiversity assessments and local capacity buildingGigaScience, 2018
- Simple Approaches to Minimally-Instrumented, Microfluidic-Based Point-of-Care Nucleic Acid Amplification TestsBiosensors, 2018
- Successful amplification of DNA aboard the International Space Stationnpj Microgravity, 2017
- Preventing PCR amplification carryover contamination in a clinical laboratory.2004